Unique ID issued by UMIN | UMIN000006209 |
---|---|
Receipt number | R000007314 |
Scientific Title | Effect and safety of supplementation of Lactobacilli powder to the patients with atopic dermatitis accompanied by food allergy |
Date of disclosure of the study information | 2011/08/22 |
Last modified on | 2015/08/22 09:08:19 |
Effect and safety of supplementation of Lactobacilli powder to the patients with atopic dermatitis accompanied by food allergy
Supplementation of Lactobacilli powder to the patients with atopic dermatitis
Effect and safety of supplementation of Lactobacilli powder to the patients with atopic dermatitis accompanied by food allergy
Supplementation of Lactobacilli powder to the patients with atopic dermatitis
Japan |
atopic dermatitis
Clinical immunology | Pediatrics | Dermatology |
Others
NO
To evaluate the effect and safety of supplementation of dry powder containing 20 mg or 0.2 mg of Lactobacilli acidophils L-92 for 24 weeks to the infants with atopic dermatitis accompanied by food allergy.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Decrease in SCORAD index after 24 week
QOL, Dose of topical corticosteroid, intestinal flora, eosinophils, IgE, LDH, AST, ALT, TARC after 24 weeks
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Food |
Supplementation of dry powder containing 20 mg of Lactobacillus acidophils L-92 once a day for 24 weeks.
Supplementation of dry powder containing 0.2 mg of Lactobacillus acidophils L-92 once a day for 24 weeks.
10 | months-old | <= |
36 | months-old | > |
Male and Female
1. Definitive atopic dermatitis which requires daily topical corticosteroid ointment.
2. Undergoing the standard treatment and skin care based on the Japanese guideline for atopic dermatitis.
3. Associated with food allergy, or avoiding some food due to the high level of specific IgE test.
4. NOT taking probiotic food or drugs daily to improve the intestinal flora.
5. NOT associated with bacterial or fungal skin infection, or any other skin diseases.
1. Suspected NOT to be able to take the powder food daily.
2. Clinical history of severe anaphylaxis caused by the small amount of milk product.
3. Any severe complications such as diabetes, gastrointestinal, renal, or heart diseases.
4. Clinical history of hypersensitivity to steroid ointment, skin moisturizer or the test food.
5. Undergoing or planning any other intervention study.
6. Any other inappropriate conditions judged by the participant doctors.
30
1st name | |
Middle name | |
Last name | Komei Ito |
Aichi Children's Health and Medical Center
Department of Allergy
1-2 Osakada, Morioka, Obu, Aichi, JAPAN
0562-43-0500
1st name | |
Middle name | |
Last name | Komei Ito |
Aichi Children's Health and Medical Center
Department of Allergy
1-2 Osakada, Morioka, Obu, Aichi, JAPAN
0562-43-0500
NPO Allergy Support Network
NPO Allergy Support Network
Other
JAPAN
None
Calpis Co.
NO
あいち小児保健医療総合センター(愛知県)
2011 | Year | 08 | Month | 22 | Day |
Partially published
Completed
2011 | Year | 04 | Month | 16 | Day |
2011 | Year | 09 | Month | 01 | Day |
2012 | Year | 03 | Month | 01 | Day |
2012 | Year | 06 | Month | 01 | Day |
2012 | Year | 09 | Month | 01 | Day |
2012 | Year | 12 | Month | 01 | Day |
2011 | Year | 08 | Month | 22 | Day |
2015 | Year | 08 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007314